
BeatBio, a Seattle life sciences startup led by former Vulcan Capital managing director Michael Kranda and former VieVax CTO Gregory Mahairas, has raised $2.5 million in seed funding from CET Capital Partners, the W Fund and others. The new funds will be used to move the company’s gene therapy product into clinical trials, an experimental… Read More…







































Most commented